Thai Doctors To Begin Beta-Thalassemia Treatment Trials In 2011
This article was originally published in PharmAsia News
Thai researchers expect to begin trials at home this year on gene-therapy technology they have been developing and testing successfully in Paris. The joint research is into a beta-thalassemia blood disorder treatment that has been successful in weaning a Frenchman off a lifetime of transfusions. The Thai researchers involved in the experiment using gene therapy are from Ramathibodi Hospital, which expects to begin a trial in December. An estimated 20 million Thais carry the disorder, now treated with bone-marrow transplants. Click here for more) "Medical Leap Gives Hope To Blood-Disorder Sufferers" - Bangkok Post (Thailand) (1/3/10)
You may also be interested in...
The company said its own calculations suggest a mid-November readout could yield a positive result, keeping it on track for an EUA before the end of 2020.
With COVID-19 continuing to wreak havoc in the EU just as throughout the globe, the European Commission is proposing new measures that will impact antigen test availability and use
Amgen’s management took a deep dive into biosimilar market dynamics during the company’s third-quarter earnings call, as the California-based biotech continued to enjoy success for biosimilars in the US and Europe.